← Eichor
Study identifier: NCT07484490 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis

Condition: Tuberculosis  ·  Sponsor: Riphah International University

PhaseNA
Planned participants34
Who can joinAll sexes, 8 Years to 14 Years
Healthy volunteersNo

About this study

The study design will be a randomized controlled trial. The data will be collected from Gulab Devi Teaching Hospital, Lahore. 34 kids aged 8 to 14 years will be randomly assigned either to an experimental group or a control group. The intervention group includes the active Cycle of Breathing technique with balloon-blowing therapy for 3 days. The control group includes the active cycle of breathing technique. Sputum secretion will be measured by 'sputum measurement cups." Dyspnea will be measured by the "Modified Borg dyspne Scale," and functional capacity will be measured by the "6-Minute Walk Test." Data will be analyzed through SPSS version 25.0.

This description comes directly from the study's public registry record.

Talk to the study team

IMRAN AMJAD, PhD  ·  9233224390125  ·  IMRAN.AMJAD@RIPHAH.EDU.PK

MUHAMMAD ASIF JAVEED, MS-PT  ·  9233224209422  ·  a.javeed@riphah.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Gulab Devi HospitalLahore, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07484490